TP53 and cancer: Furthermore, RIG-I and MDA5 are able to trigger a p53-independent alternative pathway for the induction of proapoptotic Noxa. Hence, RIG-I/MDA5-driven apoptosis is not mediated by the tumor suppressor p53 mutational status in cancer cells (74), which strongly contributes to resistance to chemo- and radiotherapy (84).